UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,425.10 -0.80 (-0.03%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
55,046.57 +150.72 (+0.27%)
TaiMed Biologics Inc. (4147.TWO)
Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
At close: 01:30PM CST
Currency in TWD
Valuation measures4
| Market cap (intra-day) | 23.81B |
| Enterprise value | 22.24B |
| Trailing P/E | N/A |
| Forward P/E | 1.11k |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 37.24 |
| Price/book (mrq) | 5.65 |
| Enterprise value/revenue | 37.13 |
| Enterprise value/EBITDA | 556.57 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -22.49% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 122.00 |
| 52-week low 3 | 76.30 |
| 50-day moving average 3 | 88.44 |
| 200-day moving average 3 | 89.99 |
Share statistics
| Avg vol (3-month) 3 | 2.07M |
| Avg vol (10-day) 3 | 545.5k |
| Shares outstanding 5 | 273.08M |
| Implied shares outstanding 6 | 274.64M |
| Float 8 | 203.02M |
| % held by insiders 1 | 18.74% |
| % held by institutions 1 | 19.96% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -21.71% |
| Operating margin (ttm) | -20.70% |
Management effectiveness
| Return on assets (ttm) | -1.73% |
| Return on equity (ttm) | -3.79% |
Income statement
| Revenue (ttm) | 598.96M |
| Revenue per share (ttm) | 2.34 |
| Quarterly revenue growth (yoy) | 149.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 16.01M |
| Net income avi to common (ttm) | -130.04M |
| Diluted EPS (ttm) | -0.50 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.32B |
| Total cash per share (mrq) | 8.67 |
| Total debt (mrq) | 743.62M |
| Total debt/equity (mrq) | 17.65% |
| Current ratio (mrq) | 11.53 |
| Book value per share (mrq) | 15.76 |
Cash flow statement
| Operating cash flow (ttm) | 85.77M |
| Levered free cash flow (ttm) | 186.91M |
© 2024 Yahoo. All rights reserved.